248 related articles for article (PubMed ID: 33545170)
1. Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial.
Saxena R; Dhiman R; Gupta V; Kumar P; Matalia J; Roy L; Swaminathan M; Phuljhele S; Velpandian T; Sharma N
Ophthalmology; 2021 Sep; 128(9):1367-1369. PubMed ID: 33545170
[No Abstract] [Full Text] [Related]
2. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048
[TBL] [Abstract][Full Text] [Related]
3. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
[TBL] [Abstract][Full Text] [Related]
4. Re: Saxena et al.: Atropine for the treatment of childhood myopia in India: multicentric randomized trial. (Ophthalmology. 2021;128:1367-1369).
Venkatesh P
Ophthalmology; 2022 May; 129(5):e60. PubMed ID: 35184893
[No Abstract] [Full Text] [Related]
5. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
6. Atropine treatment for myopia.
Brown SM
Ophthalmology; 2009 Oct; 116(10):2040; author reply 2040-1. PubMed ID: 19800530
[No Abstract] [Full Text] [Related]
7. Bifocal & Atropine in Myopia Study: Baseline Data and Methods.
Huang J; Mutti DO; Jones-Jordan LA; Walline JJ
Optom Vis Sci; 2019 May; 96(5):335-344. PubMed ID: 31046016
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for progressive myopia in the atropine therapy for myopia study.
Loh KL; Lu Q; Tan D; Chia A
Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
[TBL] [Abstract][Full Text] [Related]
9. More on the medical management of school myopia.
Palmer EA
Binocul Vis Strabismus Q; 2000; 15(4):319-20. PubMed ID: 11093087
[No Abstract] [Full Text] [Related]
10. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
[TBL] [Abstract][Full Text] [Related]
11. Topical Atropine in the Control of Myopia.
Tan D; Tay SA; Loh KL; Chia A
Asia Pac J Ophthalmol (Phila); 2016; 5(6):424-428. PubMed ID: 27898446
[TBL] [Abstract][Full Text] [Related]
12. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
[TBL] [Abstract][Full Text] [Related]
13. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
Chia A; Chua WH; Wen L; Fong A; Goon YY; Tan D
Am J Ophthalmol; 2014 Feb; 157(2):451-457.e1. PubMed ID: 24315293
[TBL] [Abstract][Full Text] [Related]
14. Low-dose atropine 0.01% for the treatment of childhood myopia: a pan-India multicentric retrospective study.
Saxena R; Gupta V; Dhiman R; Joseph E; Agarkar S; Neena R; Magdalene D; Jethani J; Ganesh SC; Patil M; Gogri P; Gadaginamath S; Sen P; Sukhija J; Mishra D; Matalia JH; Sahu A; Kapoor S; Nishanth S; Chaurasia S; Pawar N; Deori N; Sivaraman V; Bordoloi A; Tibrewal S; Singh D; Prasad P; Phuljhele S; Sharma N
Br J Ophthalmol; 2024 Mar; 108(4):588-592. PubMed ID: 38290805
[TBL] [Abstract][Full Text] [Related]
15. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
[TBL] [Abstract][Full Text] [Related]
16. [Physiological tonus and the spasm of accommodation].
Levchenko OG
Oftalmol Zh; 1985; (3):177-80. PubMed ID: 4011101
[No Abstract] [Full Text] [Related]
17. Low-concentration atropine: Co-management of myopia in children and young people in the UK - prospective case series.
Dahlmann-Noor A
Eur J Ophthalmol; 2023 Sep; 33(5):NP140-NP141. PubMed ID: 37128630
[No Abstract] [Full Text] [Related]
18. Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol.
Azuara-Blanco A; Logan N; Strang N; Saunders K; Allen PM; Weir R; Doherty P; Adams C; Gardner E; Hogg R; McFarland M; Preston J; Verghis R; Loughman JJ; Flitcroft I; Mackey DA; Lee SS; Hammond C; Congdon N; Clarke M
Br J Ophthalmol; 2020 Jul; 104(7):950-955. PubMed ID: 31653669
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis.
Ha A; Kim SJ; Shim SR; Kim YK; Jung JH
Ophthalmology; 2022 Mar; 129(3):322-333. PubMed ID: 34688698
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
